Statute Details
- Title: Medicines (Advertisements for Licensable Healthcare Services) (Exemption) Order 2023
- Act Code: MA1975-S818-2023
- Legislation Type: Subsidiary Legislation (SL)
- Authorising Act: Medicines Act 1975 (specifically section 51(4)(b))
- Enacting Minister: Minister for Health (made by Permanent Secretary, Ministry of Health)
- Date Made: 20 November 2023
- Commencement: 18 December 2023
- Current Version: Current version as at 27 March 2026
- Key Provisions: Sections 1–4 (citation/commencement, definition, exemption from section 51(1)(b), revocation)
- Related Legislation: Healthcare Services Act 2020; Medicines Act 1975
What Is This Legislation About?
The Medicines (Advertisements for Licensable Healthcare Services) (Exemption) Order 2023 is a targeted regulatory instrument that modifies how the Medicines Act 1975 applies to certain advertising activities in Singapore. In essence, it creates a narrow exemption from a medicines advertising restriction for advertisements connected to “licensable healthcare services” provided by licensed healthcare providers.
At a practical level, the Order addresses a common compliance question: when a healthcare provider licensed under the Healthcare Services Act 2020 publishes or causes to be published an advertisement relating to the healthcare services it is authorised to provide, does the Medicines Act’s advertising prohibition still apply? The Order answers “no” for the specified category of advertisements, by disapplying section 51(1)(b) of the Medicines Act 1975 in that context.
The scope is intentionally limited. The exemption is not a general advertising freedom for all healthcare advertising. It is tied to (i) the provider being licensed under the Healthcare Services Act 2020 and (ii) the advertisement being for a “licensable healthcare service” as defined by the Healthcare Services Act 2020. This structure reflects a regulatory balance: protecting the public from misleading or inappropriate medicines-related advertising, while allowing licensed healthcare providers to market their services within defined legal boundaries.
What Are the Key Provisions?
Section 1 (Citation and commencement) provides the formal identification of the instrument and states that it comes into operation on 18 December 2023. For practitioners, this matters because advertising compliance often turns on whether the relevant regulatory regime was in force at the time of publication. The Order is therefore a post-18 December 2023 compliance reference point.
Section 2 (Definition) defines the key term “licensable healthcare service” by reference to section 3(1) of the Healthcare Services Act 2020. This cross-reference is significant: it means the exemption’s scope depends on the statutory classification of healthcare services that require licensing. Rather than inventing a new definition, the Order “imports” the meaning from the Healthcare Services Act 2020, ensuring coherence between the licensing framework and the advertising exemption.
Section 3 (Exemption from section 51(1)(b) of Act) is the operative provision. It states that section 51(1)(b) of the Medicines Act 1975 does not apply to an advertisement published or caused to be published by a person who is licensed under the Healthcare Services Act 2020 to provide any licensable healthcare service.
In plain language, the exemption operates as follows:
- If the advertiser is a licensed healthcare provider under the Healthcare Services Act 2020, and
- the advertisement is for (or relates to) licensable healthcare services that the provider is licensed to provide, then
- the Medicines Act’s restriction in section 51(1)(b) is not applicable to that advertisement.
Although the extract does not reproduce the text of section 51(1)(b) itself, the structure indicates that section 51(1)(b) contains a prohibition or restriction on certain medicines-related advertising. The Order does not repeal that prohibition; it creates a carve-out for a specific category of advertisements. Practitioners should therefore treat the exemption as a disapplication of the relevant prohibition, not as a wholesale relaxation of medicines advertising rules.
Section 4 (Revocation) revokes the earlier instrument: Medicines (Advertisements by Healthcare Institutions) (Exemption) Order 2004 (G.N. No. S 279/2004). This is important for historical compliance and for understanding the regulatory evolution. The 2023 Order replaces the 2004 exemption regime, aligning it with the modern licensing framework under the Healthcare Services Act 2020 (including the concept of “licensable healthcare services”).
How Is This Legislation Structured?
This Order is structured as a short, four-section subsidiary legislation instrument:
- Section 1 sets out the citation and commencement date.
- Section 2 provides the definition of “licensable healthcare service” by reference to the Healthcare Services Act 2020.
- Section 3 contains the substantive exemption, disapplying section 51(1)(b) of the Medicines Act 1975 for qualifying advertisements.
- Section 4 revokes the earlier 2004 exemption order.
Notably, there are no additional conditions, reporting obligations, or procedural requirements stated within the Order itself. The exemption is therefore triggered by the legal status of the advertiser (licensed under the Healthcare Services Act 2020) and the subject matter (licensable healthcare services). Any further compliance expectations (for example, general advertising standards, consumer protection rules, or medicines-specific labelling/claims restrictions) would likely arise from other parts of the Medicines Act 1975 or other regulatory regimes, rather than from this Order.
Who Does This Legislation Apply To?
The exemption applies to persons who are licensed under the Healthcare Services Act 2020 to provide any licensable healthcare service. In practice, this will typically include healthcare institutions and healthcare providers that hold the requisite licences under the Healthcare Services Act 2020.
It is also limited to advertisements that fall within the exemption’s scope. The Order is not framed as an exemption for all advertising by licensed providers; it is framed as an exemption from a specific medicines advertising restriction for advertisements connected to licensable healthcare services. Accordingly, practitioners should assess whether the advertisement is genuinely for the licensable healthcare service (and not, for example, an advertisement that is effectively promoting medicines or making medicines-related claims in a way that triggers other provisions of the Medicines Act 1975).
Why Is This Legislation Important?
This Order is important because it clarifies the boundary between medicines advertising regulation and healthcare services marketing. Without such an exemption, licensed healthcare providers might face uncertainty about whether their service advertisements could be treated as “medicines advertisements” under the Medicines Act 1975, potentially exposing them to enforcement action or requiring burdensome legal review for routine marketing.
From a compliance perspective, the Order provides a practical legal basis for licensed providers to publish advertisements for licensable healthcare services without being caught by the specific prohibition in section 51(1)(b) of the Medicines Act 1975. This can reduce compliance friction for legitimate healthcare service promotion, while still preserving the Medicines Act’s regulatory framework for other categories of advertising.
For enforcement and risk management, the exemption’s narrow drafting means that practitioners should not assume blanket immunity. The exemption is contingent on licensing status and the licensable nature of the service. Where an advertisement includes medicines-related messaging, product promotion, or claims that go beyond the service being advertised, the advertisement may still be subject to other medicines-related restrictions. Therefore, lawyers advising healthcare providers should treat this Order as a targeted carve-out and conduct a careful content-based assessment alongside the provider’s licensing position.
Related Legislation
- Healthcare Services Act 2020 (including section 3(1) defining “licensable healthcare service” and the licensing framework)
- Medicines Act 1975 (including section 51(1)(b) and the enabling provision in section 51(4)(b))
- Medicines (Advertisements by Healthcare Institutions) (Exemption) Order 2004 (revoked by this Order)
Source Documents
This article provides an overview of the Medicines (Advertisements for Licensable Healthcare Services) (Exemption) Order 2023 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.